Lipoprotein(a) Internalization in HepG2 Cells is Regulated by Proprotein Convertase Subtilisin Kexin Type 9 Through the Low-Density Lipoprotein Receptor

被引：0
|
作者：
Romagnuolo, Rocco
Seidah, Nabil G.
Koschinsky, Marlys L.
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2014年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A437
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation
    Weider, Elodie
    Susan-Resiga, Delia
    Essalmani, Rachid
    Hamelin, Josee
    Asselin, Marie-Claude
    Nimesh, Surendra
    Ashraf, Yahya
    Wycoff, Keith L.
    Zhang, Jianbing
    Prat, Annik
    Seidah, Nabil G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (32) : 16659 - 16671
  • [42] Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver
    Park, SW
    Moon, YA
    Horton, JD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (48) : 50630 - 50638
  • [43] LIPOPROTEIN(A) AND PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 LEVELS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
    Galyavich, A. S.
    Gimadeeva, A.
    Galeeva, Z.
    Baleeva, L.
    ATHEROSCLEROSIS, 2020, 315 : E143 - E143
  • [44] Circulating Complex of Lipoprotein(a) and Proprotein Convertase Subtilisin/Kexin Type 9 in the Serum Measured by ELISA
    Razova, O. A.
    Afanas'eva, O. I.
    Egiazaryan, M. G.
    Sherstyuk, E. E.
    Klesareva, E. A.
    Pokrovskii, S. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2020, 169 (05) : 639 - 643
  • [45] Proprotein convertase Subtilisin/Kexin type 9 (PCSK9): Hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration
    Zaid, Ahmed
    Roubtsova, Anna
    Essalmani, Rachid
    Marcinkiewicz, Jadwiga
    Chamberland, Ann
    Hamelin, Josee
    Tremblay, Michel
    Jacques, Helene
    Jin, Weijun
    Davignon, Jean
    Seidah, Nabil G.
    Prat, Annik
    HEPATOLOGY, 2008, 48 (02) : 646 - 654
  • [46] Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation
    Kosenko, Tanja
    Golder, Mia
    Leblond, Geoffrey
    Weng, Willy
    Lagace, Thomas A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (12) : 8279 - 8288
  • [47] Circulating Complex of Lipoprotein(a) and Proprotein Convertase Subtilisin/Kexin Type 9 in the Serum Measured by ELISA
    O. A. Razova
    O. I. Afanas’eva
    M. G. Egiazaryan
    E. E. Sherstyuk
    E. A. Klesareva
    S. N. Pokrovskii
    Bulletin of Experimental Biology and Medicine, 2020, 169 : 639 - 643
  • [48] Lipoprotein(a) in atherosclerotic cardiovascular disease and proprotein convertase subtilisin/kexin-type 9 inhibitors
    Lian, Ping-an
    Zhu, Wen-qiang
    Zhao, Wei-xin
    Huang, Piao-piao
    Ran, Juan-li
    Tang, Ya-xin
    Huang, Xian-sheng
    Li, Rong
    CLINICA CHIMICA ACTA, 2025, 565
  • [49] An Update on the Clinical Development of Proprotein Convertase Subtilisin Kexin 9 Inhibitors, Novel Therapeutic Agents for Lowering Low-Density Lipoprotein Cholesterol
    Ling, Hua
    Burns, Tammy L.
    Hilleman, Daniel E.
    CARDIOVASCULAR THERAPEUTICS, 2014, 32 (02) : 82 - 88
  • [50] Ascorbic acid enhances low-density lipoprotein receptor expression by suppressing proprotein convertase subtilisin/kexin 9 expression (vol 295, 15870, 2020)
    Wang, Dandan
    Yang, Xiaoxiao
    Chen, Yuanli
    Gong, Ke
    Yu, Maoyun
    Gao, Yongyao
    Wu, Ximei
    Hu, Huaqing
    Liao, Chenzhong
    Han, Jihong
    Duan, Yajun
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2025, 301 (03)
12345